Medifast Inc. insider trading
In twelve months insiders at Medifast bought $1.7M and sold $226K on the open market; 2 of the 2 sales were under plans set months before.
New to this? How to read this page
- Insiders are the people who run the company: officers, directors and owners of 10% or more. They must report a trade on Form 4 within two business days.
- A purchase on the open market is the strongest sign: the insider spent their own money.
- A sale under a trading plan (Rule 10b5-1) says little: its dates were fixed months before. Sales outside a plan say more, but insiders sell for many reasons, such as taxes or a house.
- Grants, option exercises and shares held back for tax are left out.
- What is a Form 4? · Form 4 codes
What kind of trades
13 purchases worth $1.7M against 2 sales worth $226K; 2 of the sales were under plans set months before.
Every Form 4 line of the last twelve months, counted by kind. The grades come from the filing itself: whether the insider paid cash, whether a plan set the date, whether pay was taken in stock by choice.
Insider trades on the share price
last twelve months12 marks over twelve months, each in its grade: solid for the stronger signs, hollow or grey for the ones that say little.
The blue line is the daily close over twelve months. Each mark is one insider's trades on one day, on that day's price, sized by dollar value. Solid marks are the stronger signs; hollow and grey marks say little. Hover or tap a mark for who, how much and why.
Trades worth a closer look
A purchase stands out when two or more of these hold: a senior insider, several insiders buying within 90 days, a fall of 10% or more in the three months before, or over $1 million. A sale outside a plan is judged the same way. These are the Feed's rules.
Who traded
dollars, twelve months3 insiders traded. The most: Kiai Parsa, purchase $1.5M.
One row per insider, sold to the left and bought to the right, split by grade: the paler part of a bar is the part that says little.
How it compares
every company on the siteOpen-market sales, twelve months
Open-market purchases, twelve months
The bar ranks every company on the site from the lowest on the left to the highest on the right, in three equal thirds; the small figures under it are the values where each third starts, and the black tick is the middle company. The orange dot is this company; the grey ticks are the other companies in its industry (hover or tap for names). A hatched block is companies tied at none.
Every Form 4 line
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 28 October 2026 | Kiai Parsa, notes | Director | Purchaseafter a 27% rise over three months · 7% below its one-year high | 5,399 | $12.24 | $66,093 | Form 4 |
| 28 October 2026 | Kiai Parsa, notes | Director | Purchaseafter a 27% rise over three months · 7% below its one-year high | 158 | $12.24 | $1,934 | Form 4 |
| 29 September 2026 | Chard Daniel R, the Dan and Allyson Family Irrevocable Trust | Director | Saletrading plan set in advance · Form 144 notice 29 September 2026 | 9,544 | $11.73 | $111,951 | Form 4 |
| 28 September 2026 | Chard Daniel R, the Dan and Allyson Family Irrevocable Trust | Director | Saletrading plan set in advance · Form 144 notice 29 September 2026 | 9,545 | $11.98 | $114,338 | Form 4 |
| 26 August 2026 | Kiai Parsa, notes | Director | Purchaseafter a 4% fall over three months · 16% below its one-year high | 41,975 | $12.26 | $514,748 | Form 4 |
| 26 August 2026 | Kiai Parsa, notes | Director | Purchaseafter a 4% fall over three months · 16% below its one-year high | 1,175 | $12.26 | $14,409 | Form 4 |
| 24 August 2026 | Kiai Parsa, notes | Director | Purchaseafter a 5% fall over three months · 18% below its one-year high | 4,211 | $12.00 | $50,530 | Form 4 |
| 24 August 2026 | Kiai Parsa, notes | Director | Purchaseafter a 5% fall over three months · 18% below its one-year high | 118 | $12.00 | $1,416 | Form 4 |
| 20 August 2026 | Kiai Parsa, notes | Director | Purchaseafter a 8% fall over three months · 20% below its one-year high | 41,975 | $11.60 | $487,065 | Form 4 |
| 20 August 2026 | Kiai Parsa, notes | Director | Purchaseafter a 8% fall over three months · 20% below its one-year high | 1,175 | $11.60 | $13,634 | Form 4 |
| 19 August 2026 | Kiai Parsa, notes | Director | Purchaseafter a 8% fall over three months · 21% below its one-year high | 28,538 | $11.66 | $332,685 | Form 4 |
| 19 August 2026 | Kiai Parsa, notes | Director | Purchaseafter a 8% fall over three months · 21% below its one-year high | 799 | $11.66 | $9,314 | Form 4 |
| 26 May 2026 | Rose Jeffrey Matthew | Director | Took pay in stockown choice | 6,739 | n/a | n/a | Form 4 |
Took cash pay as 6,739 shares instead of cash. The stock had risen 25% in the three months before. The filing's own wordsThe reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer.Form 4 footnote, as filed | |||||||
| 26 May 2026 | Kiai Parsa | Director | Took pay in stockown choice | 7,637 | n/a | n/a | Form 4 |
Took cash pay as 7,637 shares instead of cash. The stock had risen 25% in the three months before. The same insider also bought shares on the open market on 19 August 2026. The filing's own wordsThe reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer.Form 4 footnote, as filed | |||||||
| 11 May 2026 | Schlackman Scott | Director | Purchaseafter a 10% rise over three months · 19% below its one-year high | 2,500 | $12.53 | $31,325 | Form 4 |
| 8 May 2026 | Schlackman Scott | Director | Purchaseafter a 11% rise over three months · 17% below its one-year high | 2,500 | $12.65 | $31,625 | Form 4 |
| 20 March 2026 | Chard Daniel R, dan and Allyson as Joint Tenants | Chairman & CEO | Purchaseafter a 16% fall over three months · 34% below its one-year high | 17,678 | $10.11 | $178,725 | Form 4 |